A Phase II Study of Sunitinib in Recurrent or Progressive Brain Tumors in Pediatric and Young Adult Patients

Grant

Date/time Interval

  • October 10, 2012 - October 9, 2013

    • Awarded By

    Total Award Amount

  • 20300.00

    • Direct Costs

  • 16111.00

    • Sponsor Award Id

    • Contributor

  • Gregory Friedman M.D.   Investigator